Essure® was implanted in thousands of women’s fallopian tubes from 2002 to 2016, designed to be a permanent sterilization birth control device. Unfortunately, the device migrates, perforates organs, breaks and causes severe reactions and medical conditions, requiring surgical removal. In 2016, the Food and Drug Administration (FDA) required a black box warning, additional clinical trials on safety and efficacy, and a multi-page physician checklist to ensure patients implanted are aware of the true risks associated with the device.

In December of 2016, Kim Dougherty was appointed to the Executive Committee of the Essure® consolidated litigation in California and successfully argued early statute of limitations motions, resulting in saving many women’s potential claims.

National Mass Tort Attorneys
Headquartered in Denver
Toll Free: 866-795-9529